Some investors have forgotten, and some investors just don’t know, but if you are a retail investor, over-trading is generally very bad for your wealth. This article provides a few reminders, perhaps eye openers, starting with this “oldie but goodie” chart about just how bad the average investor really is.
This article reviews a big market shift that is just starting, and how to profit from it. Tax reform and shifting monetary policies are slowing recent winners (e.g. large growth stocks and technology) and propelling some attractive mean reversion opportunities. In particular, we like small cap, value, and US stocks right now. In September, all three Blue Harbinger strategies extended their long-term track records of outperforming the S&P 500.
Caterpillar has a lot more long-term upside potential, but we sold 100% of our Caterpillar shares this morning for a gain of +110% after owning them for 19 months. Before describing the 5 better income-producing investments, we review why we sold our shares of Caterpillar. Our 5 better options than Caterpillar for income-seeking investors are organized from least to most risky, but they’re all attractive, in our view.
Long-term investing is a proven strategy to build wealth, and it is a lot more powerful than many investors realize. However, whether you are brand new to investing or a seasoned pro, there are seven terrible mistakes (deadly sins) that can easily prevent you from achieving your goals.
Healthcare stocks (XLV) have gained 14.5% over the last year, thereby keeping pace with the overall market as measured by the S&P 500 (SPY) which gained 15.0% over the same time period. However, there are a variety of reasons why healthcare REITs have significantly underperformed, many of them delivering negative returns, as shown in the following table.
Ventas (VTR) and Welltower (HCN) are both healthcare REITs focused mainly on senior housing. They face similar risks and similar opportunities. This article describes ten similarities between the two and then provides 10 reasons why we believe one is more attractive than the other. We've also ranked the winner on our broader list of Top 5 Big-Dividend Healthcare REITS Worth Considering.
There are two big risks that have investors scared about Omega Healthcare (OHI) and its big +8% dividend yield. As contrarians, we like the opportunity this healthcare REIT presents. Watch our recent video to learn more.
As a follow-up to our members-only article on New Residential at the beginning of this week, this article takes a deep dive into a variety of big risks as well as reasons to be optimistic (and we're not only talking about the big 12.5% dividend yield).
There is a reason why Omega Healthcare Investors’ (OHI) yield (7.7%) and short-interest (21.2%) are so high. And yesterday’s release of the new GOP healthcare bill did nothing to improve the situation This article provides an update on Omega, highlights several bad reasons to invest, and concludes with our views on the right way to think about this high-yield REIT.
According to Bank of America, we're likely setting up for a “big top” in stock markets this fall. And if you cannot stomach short- and intermediate-term volatility, this article highlights 10 safe high-income investment opportunities that we believe are worth considering.
Blue Harbinger's Mark Hines had the pleasure of doing an interview about Simon Property Group with Cheddar TV and Seeking Alpha this morning. In a nutshell, our thesis is that Simon Property Group is a hated REIT (it's very out of favor), and as contrarians this is exactly why we like it. Plus its attractive valuation and its big safe growing dividend (currently 4.4% yield).
The aggressive large cap growth stocks that have been dominating the market this year (e.g. Facebook, Amazon, Netflix and Google/Alphabet) have recently been showing signs of capitulation. Rather than chasing after the most popular growth stocks, this article highlights 10 big safe income-generating investment opportunities that we believe are worth considering.
If you’re looking for a source of income in your portfolio, but all of the dividend growth stocks you like seem expensive, then you may want to consider selling put options. For those of you inclined, this article details five specific dividend-growth stocks (Bank of America, Gilead, IBM, Verizon and Goldman Sachs) that currently offer attractive put option premiums for income-focused investors.
If you are looking for big stable growing income, Enterprise Products Partners (EPD) is worth considering. This midstream energy services provider offers an attractive 6.1% distribution yield, and the shares are on sale, in our view. Considering the company’s large and strategic footprint, stable fee-based income, vertical integration, and growth (both in assets and distributions), we have added it to our list of 10 Attractive High-Yield Blue Chips Worth Considering.
If you are an income-focused investor, and you appreciate the price appreciation potential of a good contrarian opportunity, then you may want to consider some of the ideas highlighted in this article. Specifically, we provide an overview (and data) on “Dogs of the Dow,” “Dividend Aristocrats," retail REITs, healthcare REITs, MLPs, closed end funds, and options strategies, including ten of our favorite high-yield, contrarian, blue chip opportunities right now.
To the chagrin of yield-chasers, Frontier Communications (FTR) finally cut its big dividend. Specifically, the dividend was reduced by 62% last week (it now sits at 13.2%), and the stock is now down 64% this year. For your consideration, this article reviews the potential risks and rewards of investing in Frontier's high-yield bonds (+10% YTM), big-dividend stock, and leveraged options.
Last week was volatile and painful for many higher-yielding securities. For example, REITs, BDCs and MLPs (all known for high-yield) sold off significantly. We are in no way suggesting last week was a bottom, but we do believe some high-quality companies have sold off thereby making for more attractive entry points for long-term investors. This article highlights 100 high-yield equities that sold-off last week, and then reviews 10 specific opportunities that long-term income-focused investors may want to consider.
This article offers three explanations for the recent strong performance from high-yield BDCs, three reasons why we believe they’ll be challenged going forward, we consider three counterpoints to our thesis, and we highlight three specific BDCs (Prospect, Main Street and Fidus) that seem particularly overvalued right now. Finally, we offer 7 specific high-yield REIT ideas (ranked from best to worst) that offer a very attractive alternative for income-focused investors.
MedEquities Realty Trust (MRT) is an attractive healthcare REIT that offers a big 7.2% dividend yield. It is growing rapidly, and it trades at compelling price-to-book and price-to-forward-AFFO ratios. And apparently, hedge funds like it too. This article provides an overview of the bull case for MedEquities, highlights some of the significant risks, and then offers an idea about how to invest in this potentially big opportunity.
Understandably, many investors are not excited about traditional fixed income investments because interest rates are so low and rising (as rates go up, bond prices go down). Also understandably, many investors are not excited about high-yield stocks because they usually involve much more volatility and risk than bonds. However, healthcare REITs is one corner of the market that risk-averse income-focused investors may want to consider.